The pharmaceutical market in India ranks among the top twenty markets in the world with the potential to move up in ranking rather quickly. This market will be essential for pharmaceutical companies exploring new opportunities for growth. Developing regions will be an integral part of expansion for companies looking to capture a larger portion of the worldwide market. This report Pharmaceutical Market in India provides market watchers with needed information on this growing market, including:

• Market Size and Forecast
• Indian Market Share of Key Competitors
• Population and Epidemilogical Statistics for the Indian Market
• Pharmaceutical Market by Product Category
• Company Profiles of Global Companies
• Profiles of Key Domestic (Indian) Companies

The report includes incidence of conditions prevalent in the region discussed, health statistics related to the industry, birth rates, world population, regional population and issues affecting the market as a whole. Provided is an overview of demographics, information about products segments and market indicators, market estimates and forecasts.

The information for this report was gathered using both primary and secondary research including comprehensive research of secondary sources such as company literature, databases, investment reports, and medical and business journals. Telephone interviews and email correspondence were the primary method of gathering information. For the purpose of this study,

Kalorama Information conducted interviews with industry officials, consultants, health care providers, and government personnel. These sources were the primary basis in gathering information specifically relating to revenue and market share data presented in this report. Additional interviews were completed with relevant company representatives including marketing directors, division managers, and product representatives. All market data pertains to the world market at the manufacturers’ level. The base year for data was 2007. Historical data was provided for the years 2005 and 2006, with forecast data provided for 2008 through 2012. Compound annual growth rates (CAGRs) are provided for the 2005-2007 and 2008-2012 periods for each region and/or segment covered. The forecasted market analysis for 2008-2012 was largely based on demographic trends, new developments, and global expansion.

Related Reports:

The Worldwide Market for Anti-Infectives (Antifungals, Antibacterials and Antivirals)
Oct 1, 2009 - KLI2435380 - $3,500.00

The World Market for Biosimilars and the Potential for US Follow-on Biologics
Aug 1, 2009 - KLI2402283 - $3,700.00

Infectious Disease Diagnostic Markets
Aug 1, 2009 - KLI2391680 - $3,500.00

Who is Who in Clinical Diagnostics in India (Markets, Distributors, Companies, Country Overview)
Aug 1, 2009 - KLID2254015 - $3,995.00

H1N1 (Swine Influenza) Market Assessment (Latest Data, Company Profiles, Implications for Immunoassays and Molecular Assays)
May 1, 2009 - KLI2241990 - $800.00

Rx to OTC Switches 2009
May 1, 2009 - KLI2196300 - $3,500.00

Pharmaceutical Markets in Russia
Jan 1, 2009 - KLI2074032 - $995.00

Nosocomial Infections: Market Impact on Diagnostics and Therapeutics: (MRSA, HAP, C. diff and other Hospital Acquired Infections)
Jan 1, 2009 - KLI2065254 - $3,500.00

Pharmaceutical Outsourcing Post-Launch : Contract Manufacturing, Biomanufacturing and Sales, 3rd Edition
Jan 1, 2009 - KLI1646605 - $3,500.00

The World Market for Gastrointestinal Endoscopy Equipment
Jan 1, 2009 - KLI1646595 - $3,500.00